Biotech · Private company
Ensoma
Track this companyFree. Adds Ensoma to your Dealase workspace and tells you when its record changes.
Clinical trials62 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- EN-374Phase 2 · X-Linked Chronic Granulomatous DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- MGTA-145Phase 2 · Sickle Cell DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- MGTA-145Phase 2 · Related Donors Donating PBSC to a Family MemberClinicalTrials.gov · fetched Nov 12, 2026
- PlerixaforPhase 2 · Sickle Cell DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- PlerixaforPhase 2 · Related Donors Donating PBSC to a Family MemberClinicalTrials.gov · fetched Nov 12, 2026
- MGTA-145Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- MGTA-145Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- plerixaforPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Study of EN-374 Gene Therapy in Participants With X-Linked Chronic Granulomatous DiseasePHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Aug 5, 2025ClinicalTrials.gov NCT06876363 · fetched Nov 12, 2026
- Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous DiseaseRECRUITING · started Nov 18, 2024ClinicalTrials.gov NCT06605378 · fetched Nov 12, 2026
- Study of MGTA-145 and Plerixafor in Patients With Sickle Cell DiseasePHASE2 · TERMINATED · started Jun 24, 2022ClinicalTrials.gov NCT05445128 · fetched Nov 12, 2026
- MGTA-145 + Plerixafor in the Mobilization of HSCs for Allogeneic Transplant in Hematologic MalignanciesPHASE2 · TERMINATED · started Jun 16, 2021ClinicalTrials.gov NCT04762875 · fetched Nov 12, 2026
- Study Assessing PK and Safety of MGTA-145 in Subjects With Normal Estimated GFR and Varying Degrees of Renal ImpairmentPHASE1 · COMPLETED · started Nov 7, 2019ClinicalTrials.gov NCT04154670 · fetched Nov 12, 2026
- Study Assessing Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MGTA-145 in Healthy Volunteers as a Single Agent or in Combination With PlerixaforPHASE1 · COMPLETED · started Apr 22, 2019ClinicalTrials.gov NCT03932864 · fetched Nov 12, 2026